Provided by Tiger Fintech (Singapore) Pte. Ltd.

Mirum Pharmaceuticals, Inc.

43.45
+0.91002.14%
Post-market: 43.450.00000.00%19:21 EDT
Volume:280.20K
Turnover:12.10M
Market Cap:2.15B
PE:-23.48
High:43.68
Open:42.38
Low:41.99
Close:42.54
Loading ...

Mirum’s CTEXLI™ (chenodiol) Tablets Receives FDA Approval for Treatment of Cerebrotendinous Xanthomatosis (CTX)

Business Wire
·
24 Feb

Analysts Offer Insights on Healthcare Companies: Mirum Pharmaceuticals (MIRM) and AMN Healthcare Services (AMN)

TIPRANKS
·
24 Feb

Mirum Pharmaceuticals' Lipid Storage Disease Treatment Gets FDA Approval

MT Newswires Live
·
22 Feb

FDA Approves Mirum Pharmaceuticals Treatment for Lipid-Storage Disease

Dow Jones
·
22 Feb

FDA Approves First Treatment for Cerebrotendinous Xanthomatosis, a Rare Lipid Storage Disease

THOMSON REUTERS
·
22 Feb

US FDA approves Mirum Pharma's genetic disorder drug

Reuters
·
22 Feb

BRIEF-FDA Approves First Treatment For Cerebrotendinous Xanthomatosis, A Rare Lipid Storage Disease

Reuters
·
22 Feb

FDA Approves First Treatment for Cerebrotendinous Xanthomatosis, a Rare Lipid Storage Disease

THOMSON REUTERS
·
22 Feb

High Growth Tech Stocks in United States to Watch

Simply Wall St.
·
20 Feb

Mirum Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)

THOMSON REUTERS
·
11 Feb

Netflix Near Record High, So Are These Stocks: Build Your Growth Stock Watchlist With Top Stock Screens

Blockhead
·
28 Jan

Mirum Pharmaceuticals (MIRM) Upgraded to Buy: What Does It Mean for the Stock?

Zacks
·
25 Jan

Top Analyst Reports for Home Depot, RTX & Applied Materials

Zacks
·
18 Jan

MIRM Shares Rise 12% in a Week on Robust Preliminary 2024 Results

Zacks
·
17 Jan

Exploring Three High Growth Tech Stocks in the United States

Simply Wall St.
·
15 Jan

Axsome (AXSM) Moves 11.5% Higher: Will This Strength Last?

Zacks
·
14 Jan

Mirum Pharmaceuticals Announces Preliminary Unaudited 2024 Net Product Sales and Cash Balance and Provides Corporate Updates

THOMSON REUTERS
·
13 Jan

Mirum Pharmaceuticals Inc: 2025 Expected Global Net Product Sales of $420 Mln to $435 Mln

THOMSON REUTERS
·
13 Jan

Mirum Pharmaceuticals: Expect 2024 Net Product Sales of About $336 Mln

THOMSON REUTERS
·
13 Jan

Mirum Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)

THOMSON REUTERS
·
11 Jan